Status:
COMPLETED
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
Lead Sponsor:
Danish Pain Research Center
Collaborating Sponsors:
NeuroSearch A/S
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Purpose: To evaluate the efficacy, tolerability and safety of NS1209 compared to lidocaine and placebo in patients with peripheral chronic neuropathic pain.
Eligibility Criteria
Inclusion
- Age \>18 years
- Neuropathic pain and allodynia after a peripheral nerve injury (VAS \>= 4)
Exclusion
- Patients who cannot cooperate and do no understand Danish
- Fertile women
- Clinically significant abnormality or disease
- Drug and alcohol abuse
- Clinically abnormal ECG
- Hypersensitivity to any of the treatments
- Patients in treatment with cimetedin, antidepressants, antipsychotics, antiepileptics except gabapentin, anticoagulants, Na channel blockers and beta blockers
- Patients who have previously been treated in a NS1209 study
- Patients treated with an investigational drug
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00258622
Start Date
November 1 2005
End Date
February 1 2007
Last Update
November 16 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Pain Research Center, Aarhus University Hospital
Aarhus, Denmark, 8000